We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+23.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.4B
AUM Growth
-$5.58B
(-25%)
Cap. Flow
-$3.87B
Cap. Flow
% of AUM
-23.65%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$76.6M |
| 3 |
Lowe's Companies
LOW
|
+$75.4M |
| 4 |
Monster Beverage
MNST
|
+$64.6M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$114M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 3 |
Trane Technologies
TT
|
+$106M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 11.27% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAFE
1776
Safehold
SAFE
$1.13B
| $13K | ﹤0.01% |
229
+164
| +252% | +$8.26K |
|
|
SCS
1777
DELISTED
Steelcase
SCS
| $13K | ﹤0.01% |
1,164
-1,163
| -50% | -$12.7K |
|
1778
US Physical Therapy
USPH
$1.22B
| $13K | ﹤0.01% |
168
+77
| +85% | +$5.62K |
|
1779
Vicor
VICR
$9.42B
| $13K | ﹤0.01% |
+186
| New | +$10.4K |
|
1780
NCR Voyix
VYX
$1.12B
| $13K | ﹤0.01% |
1,332
-26
| -2% | -$298 |
|
1781
Warner Bros
WBD
$63.9B
| $13K | ﹤0.01% |
689
-181,088
| -100% | -$3.91M |
|
|
XHR
1782
Xenia Hotels & Resorts
XHR
$1.85B
| $13K | ﹤0.01% |
1,431
+225
| +19% | +$2.1K |
|
1783
Corpay
CPAY
$25.5B
| $13K | ﹤0.01% |
54
-155,988
| -100% | -$37M |
|
|
ONC
1784
BeOne Medicines Ltd
ONC
$33.4B
| $13K | ﹤0.01% |
70
+41
| +141% | +$6.67K |
|
|
CXP
1785
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $13K | ﹤0.01% |
994
-1,094,445
| -100% | -$14.4M |
|
1786
Agios Pharmaceuticals
AGIO
$1.95B
| $12K | ﹤0.01% |
229
-147
| -39% | -$6.81K |
|
1787
Allegiant Air
ALGT
$2.66B
| $12K | ﹤0.01% |
119
+28
| +31% | +$2.56K |
|
1788
AngioDynamics
ANGO
$610M
| $12K | ﹤0.01% |
1,191
+644
| +118% | +$6.64K |
|
1789
A.O. Smith
AOS
$8.24B
| $12K | ﹤0.01% |
261
-5,832
| -96% | -$255K |
|
|
BLUE
1790
DELISTED
bluebird bio
BLUE
| $12K | ﹤0.01% |
16
+12
| +300% | +$9.05K |
|
|
BZUN
1791
Baozun
BZUN
$173M
| $12K | ﹤0.01% |
328
+102
| +45% | +$3.2K |
|
|
ELP
1792
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $12K | ﹤0.01% |
2,740
+460
| +20% | +$2.04K |
|
|
HPI
1793
John Hancock Preferred Income Fund
HPI
$428M
| $12K | ﹤0.01% |
+637
| New | +$11.5K |
|
|
HSII
1794
DELISTED
Heidrick & Struggles
HSII
| $12K | ﹤0.01% |
606
+191
| +46% | +$4.2K |
|
1795
iShares US Aerospace & Defense ETF
ITA
$14.1B
| $12K | ﹤0.01% |
154
-2,000
| -93% | -$158K |
|
1796
Itaú Unibanco
ITUB
$93B
| $12K | ﹤0.01% |
3,623
-3,698
| -51% | -$12K |
|
1797
John B. Sanfilippo & Son
JBSS
$954M
| $12K | ﹤0.01% |
142
+54
| +61% | +$4.58K |
|
1798
Lear
LEA
$7.33B
| $12K | ﹤0.01% |
111
+11
| +11% | +$1.09K |
|
1799
Grupo Aeroportuario del Pacifico
PAC
$13.1B
| $12K | ﹤0.01% |
181
-113
| -38% | -$7.21K |
|
1800
Petrobras
PBR
$123B
| $12K | ﹤0.01% |
1,502
-15
| -1% | -$109 |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.
- Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
- Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
- Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
- Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
- Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
- Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.